表紙
市場調査レポート

創薬技術の世界市場

Drug Discovery Technologies

発行 BCC Research 商品コード 244530
出版日 ページ情報 英文 253 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
創薬技術の世界市場 Drug Discovery Technologies
出版日: 2015年02月20日 ページ情報: 英文 253 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

世界の創薬技術の市場は、2013年に395億ドル、2014年には465億ドルの市場規模に達しました。2014年から2019年にかけては11.3%のCAGRで推移し、2019年には約795億ドルの規模に成長すると予測されています。

当レポートでは、世界の創薬技術市場の現状と見通しについて調査し、主な研究領域と創薬技術、新たな革新的技術開発の動向、主要製品市場の予測、地域別の動向、業界のリーダーと市場シェア、特許動向、市場成長への各種影響因子の分析、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 概要

  • 分類
    • ハイスループットスクリーニング (HTS)
    • 創薬向け生物学的分析機器
      • 高性能液体クロマトグラフィ機器・備品
      • 質量分光分析機器・備品
      • 創薬におけるNMR
      • X線結晶構造解析
      • 顕微鏡
      • 光学顕微鏡
      • 蛍光顕微鏡
      • 共焦顕微鏡
      • 電子顕微鏡
    • 創薬向けセルベースアッセイ・試薬
      • セルベースアッセイ
      • 標的としてのGタンパク質共役型受容体
      • セルベースアッセイ開発の標的としてのイオンチャネル
      • セルバイオロジー試薬
      • 幹細胞研究
    • プロテオミクス創薬
      • タンパク質間相互作用
      • タンパク質マイクロアレイ (タンパク質チップ技術)
      • 二次元ゲル電気泳動 (2DGE)
    • ゲノミクス創薬
      • ポリメラーゼ連鎖反応 (PCR)
      • DNAマイクロアレイ
      • RNA干渉
      • 次世代シーケンシング
      • エピジェネティック薬
      • HDAC
      • DNMT
      • MT
    • 創薬プラットフォームとしてのバイオインフォマティクス
    • その他
      • 代謝額
      • コンビナトリアルケミストリー
      • システムバイオロジー
      • ナノテクノロジー
  • 創薬プロセス

第4章 法規制

第5章 新たな開発

第6章 市場分析

  • タイプ別市場
    • ハイスループットスクリーニング
      • 市場概要
      • 市場収益
    • 生物学的分析機器
      • 市場概要
      • 市場収益
    • 創薬向けセルベースアッセイ・試薬
      • 市場概要
      • 市場収益
    • プロテオミクス創薬
      • 市場概要
      • 市場収益
    • ゲノミクス創薬
      • 市場概要
      • 市場収益
    • 創薬プラットフォームとしてのバイオインフォマティクス
      • 市場概要
      • 市場収益
    • その他の創薬技術
      • 市場概要
      • 市場収益
    • 市場シェア
  • 地域別市場
    • 市場概要
    • 市場収益
    • ハイスループットスクリーニング
      • 市場概要
      • 市場収益
    • 創薬向け生物学的分析機器
      • 市場概要
      • 市場収益
      • 高性能液体クロマトグラフィ機器・備品
      • 質量分光分析機器・備品
      • NMR
      • 顕微鏡
      • X線結晶構造解析
    • 創薬向けセルベースアッセイ・試薬
      • 市場概要
      • 市場収益
      • 創薬向けセルベースアッセイ
      • セルバイオロジー試薬
    • プロテオミクス FOR 創薬
      • 市場概要
      • 市場収益
      • 二次元ゲル電気泳動 (2DGE)
      • タンパク質マイクロアレイ/タンパク質チップ
    • ゲノミクス FOR 創薬
      • 市場概要
      • 市場収益
      • ポリメラーゼ連鎖反応
      • DNAマイクロアレイ
      • RNA干渉
      • 次世代シーケンシング
      • エピジェネティクス
    • 創薬向けバイオインフォマティクス
      • 市場概要
      • 市場収益
    • その他の創薬技術
      • 市場概要
      • 市場収益
      • 代謝学
      • コンビナトリアルケミストリー
      • システムバイオロジー
      • ナノテクノロジー
    • 市場シェア

第7章 産業構造

  • ハイスループットスクリーニング
    • 市場のリーダー
    • 市場シェア
  • 生物学的分析機器
    • 市場のリーダー
    • 市場シェア
  • セルベースアッセイ・試薬
    • 市場のリーダー
    • 市場シェア
  • プロテオミクス
    • 市場のリーダー
    • 市場シェア
  • ゲノミクス
    • 市場のリーダー
    • 市場シェア
  • バイオインフォマティクス
    • 市場のリーダー
    • 市場シェア
  • その他の創薬技術
    • 市場のリーダー
    • 市場シェア

第8章 目的別市場

  • 医薬品・バイオ医薬品の製造
  • 医薬品・バイオ医薬品のR&D
  • 世界の創薬技術市場:目的別
    • 市場シェア
  • ハイスループットスクリーニング
    • 市場概要
    • 市場収益
  • 生物学的分析機器
    • 市場概要
    • 市場収益
  • セルベースアッセイ・試薬
    • 市場概要
    • 市場収益
  • プロテオミクス技術
    • 市場概要
    • 市場収益
  • ゲノミクス技術
    • 市場概要
    • 市場収益
  • バイオインフォマティクス技術
    • 市場概要
    • 市場収益
  • その他の創薬技術
    • 市場概要
    • 市場収益

第9章 特許分析

第10章 現在の状況

  • 新しい創薬技術・プラットフォーム
  • 創薬技術市場への影響因子
  • 創薬技術市場の現在の成長推進因子
  • 提携/買収

第11章 企業プロファイル

  • AB SCIEX
  • ACCELRYS (NOW BIOVIA)
  • AFFYMETRIX INC.
  • AGILENT TECHNOLOGIES INC
  • AMETEK PROCESS INSTRUMENTS
  • APPLIED MATHS NV
  • BAYER TECHNOLOGY SERVICES GMBH
  • BD BIOSCIENCES
  • BECKMAN COULTER INC.
  • BIOCRATES LIFE SCIENCES AG
  • BIOMAX INFORMATICS AG
  • BIO-RAD LABORATORIES INC.
  • BIOTECH SUPPORT GROUP
  • BIOTEK INSTRUMENTS INC.
  • BRUKER
  • CEPHEID
  • CHARLES RIVER LABORATORIES INTERNATIONAL INC.
  • CHENOMX
  • CISBIO BIOASSAYS
  • CODEX BIOSOLUTIONS INC.
  • COMPUGEN LTD.
  • EMD MILLIPORE
  • GE HEALTHCARE LIFESCIENCES
  • GENEVA BIOINFORMATICS SA
  • GENOMATIX SOFTWARE GMBH
  • GENOSPLICE TECHNOLOGY
  • HAMILTON ROBOTICS INC.
  • HIGHCHEM LTD. SLOVAKIA
  • 日立ハイテクノロジーズ
  • HUMAN METABOLOME TECHNOLOGIES INC.
  • ILLUMINA INC.
  • INTEGRATED DNA TECHNOLOGIES INC.
  • IROA TECHNOLOGIES (FORMERLY NEXTGEN METABOLOMICS)
  • JEOL LTD
  • LEICA MICROSYSTEMS
  • LONZA GROUP AG
  • METABOLON INC.
  • MOLECULAR DEVICES LLC
  • MULTISPAN INC.
  • OPGEN INC.
  • PERKINELMER INC.
  • PROMEGA CORP.
  • QIAGEN NV
  • ROCHE HOLDING LTD
  • 島津製作所
  • SIDMAP LLC
  • SIGMA-ALDRICH CORP.
  • SOMALOGIC INC.
  • THERMO FISHER SCIENTIFIC INC.
  • THOMSON REUTERS
  • WATERS CORP.
  • ZEISS

第12章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BIO020E

The global market for drug discovery technologies reached nearly $39.5 billion and $46.5 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to nearly $79.5 billion for the period 2014-2019.

This report provides:

  • An overview of the global markets for drug discovery technologies.
  • Analyses of global market trends, with data from 2012-2014, and projections of CAGRs through 2019.
  • A look at the current state of the drug discovery market, existing platforms and products on the market, and detailed analysis of the competitive environments including new, potential venues for novel technologies and approaches.
  • Descriptions of various products such as bioanalytical instruments, high-throughput screening devices, informatics, and microarrays.
  • Analyses of the main positive and negative factors in each sector of the market, potential future trends, and emerging technologies accross different segments of the industry.

image1

REPORT SCOPE

SCOPE OF THE STUDY

BCC Research conducted an assessment of the market, which includes the global and regional breakdown of sales data, market forecasting, available drug discovery technologies in the market, application of the technologies in commercial and research practice, regulatory aspects, patent analysis, market leaders and market share and so forth for the drug discovery technologies.

The report offers a summary of the global drug discovery technologies market along with region-wise sales analysis of regions such as North America (the U.S. and Canada), Europe and emerging markets (Asian countries, South America, parts of Africa, Russia etc.). The application of drug discovery technologies is based on the commercial and R&D uses of those technologies/products/platforms.

The sales data for the global and regional markets were substantiated for the present and projected values through statistical analysis. The technology details in the report are based on their present/prospective application and expediency.

ANALYSTS' CREDENTIALS

A team of professionals in the biotechnology industry carried out this study. The project manager is Shalini S. Dewan, who holds a master's degree in pharmaceutical chemistry and has more than 14 years of industry experience. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest, from ibuprofen to 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S.

Table of Contents

CHAPTER 1 INTRODUCTION

  • STUDY OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE
  • SCOPE OF THE STUDY
  • METHODOLOGY
  • INFORMATION SOURCES
  • ANALYSTS' CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 EXECUTIVE SUMMARY

  • SUMMARY TABLE GLOBAL REVENUE OF DRUG DISCOVERY TECHNOLOGIES, BY REGION, THROUGH 2019 ($ MILLIONS)
  • SUMMARY FIGURE GLOBAL REVENUE OF DRUG DISCOVERY TECHNOLOGIES, BY REGION, 2012-2019 ($ MILLIONS)

CHAPTER 3 OVERVIEW

  • CLASSIFICATION
    • HIGH-THROUGHPUT SCREENING (HTS)
    • BIOANALYTICAL INSTRUMENTS FOR DRUG DISCOVERY
      • High-performance Liquid Chromatography Equipment and Accessories
      • Mass Spectrometry Equipment and Accessories
      • NMR in Drug Discovery
      • X-ray Crystallography
      • Microscopy
      • Light Microscopy
      • Fluorescence Microscopy
      • Confocal Microscopy
      • Electron Microscopy
    • CELL-BASED ASSAYS AND REAGENTS FOR DRUG DISCOVERY
      • Cell-based Assays
        • G Protein-coupled Receptors as Targets
        • Ion Channel as Target for Cell-based Assay Development
      • Cell Biology Reagents
      • TABLE 1 CELL BIOLOGY REAGENTS AND THEIR FUNCTIONS
      • Stem Cell Research
    • PROTEOMICS DRUG DISCOVERY
      • Protein-protein Interaction
      • Protein Microarrays (Protein Chip Technology)
      • TABLE 2 PROTEIN MICROARRAY AND THEIR FUNCTIONS
        • Two-Dimensional Gel Electrophoresis (2DGE)
    • GENOMICS DRUG DISCOVERY
      • Polymerase Chain Reaction (PCR)
      • DNA Microarrays
      • RNA Interference
      • Next-generation Sequencing
      • Epigenetic Drugs
        • Histone Deacetylases (HDACs)
        • DNA Methyltransferases (DNMT)
        • Histone Methyltransferases (MT)
    • BIOINFORMATICS AS PLATFORM FOR DRUG DISCOVERY
    • OTHER - METABOLOMICS-BASED TECHNOLOGIES, COMBINATORIAL CHEMISTRY, SYSTEMS BIOLOGY, NANOTECHNOLOGY
      • Metabolomics
      • Combinatorial Chemistry
      • TABLE 3 DIFFERENCE BETWEEN SOLID-PHASE AND SOLUTION-PHASE SYNTHESIS
      • Systems Biology
      • Nanotechnology
  • DRUG DISCOVERY PROCESS
  • FIGURE 1 DRUG DISCOVERY PROCESS

CHAPTER 4 REGULATORY ASPECTS

  • FIGURE 2 STEPS TO DRUG DISCOVERY UNTIL REGULATORY APPROVAL
  • DRUG DEVELOPMENT TECHNOLOGIES AND REGULATIONS
    • HIGH-THROUGHPUT SCREENING
    • BIOANALYTICAL INSTRUMENTS
    • CELL-BASED ASSAYS
    • GENOMICS AND PROTEOMICS
      • Microarray
    • BIOINFORMATICS
    • NANOTECHNOLOGY
    • REGULATORY DEVELOPMENTS OF DRUG DISCOVERY TECHNOLOGIES

CHAPTER 5 NEW DEVELOPMENTS

  • TABLE 4 NEW DEVELOPMENTS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2014
  • TABLE 5 AWARDS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2014
  • TABLE 6 NEW DEVELOPMENTS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2013
  • TABLE 7 AWARDS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2013
  • TABLE 8 NEW DEVELOPMENTS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2012
  • TABLE 9 AWARDS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2012

CHAPTER 6 MARKET ANALYSIS

  • MARKET BY TYPE
  • TABLE 10 GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY TYPE, THROUGH 2019 ($ MILLIONS)
  • FIGURE 3 GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY TYPE, 2012-2019 ($ MILLIONS)
    • HIGH-THROUGHPUT SCREENING
      • Market Overview
      • Market Revenue
      • TABLE 11 GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, THROUGH 2019 ($ MILLIONS)
      • FIGURE 4 GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012-2019 ($ MILLIONS)
    • BIOANALYTICAL INSTRUMENTS
      • Market Overview
      • Market Revenue
      • TABLE 12 GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS AND TECHNOLOGY, BY TYPE, THROUGH 2019 ($ MILLIONS)
      • FIGURE 5 GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS AND TECHNOLOGY, BY TYPE, 2012-2019 ($ MILLIONS)
    • CELL-BASED ASSAYS AND REAGENTS FOR DRUG DISCOVERY
      • Market Overview
      • Market Revenue
      • TABLE 13 GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS BY TYPE, THROUGH 2019 ($ MILLIONS)
      • FIGURE 6 GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS BY TYPE, 2012-2019 ($ MILLIONS)
    • PROTEOMICS DRUG DISCOVERY
      • Market Overview
      • Market Revenue
      • TABLE 14 GLOBAL REVENUE FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGY BY TYPE, THROUGH 2019 ($ MILLIONS)
      • FIGURE 7 GLOBAL REVENUE FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGY BY TYPE, 2012-2019 ($ MILLIONS)
    • GENOMICS DRUG DISCOVERY
      • Market Overview
      • Market Revenue
      • TABLE 15 GLOBAL REVENUE FOR GENOMIC DRUG DISCOVERY TECHNOLOGY BY TYPE, THROUGH 2019 ($ MILLIONS)
      • FIGURE 8 GLOBAL REVENUE FOR GENOMIC DRUG DISCOVERY TECHNOLOGY BY TYPE, 2012-2019 ($ MILLIONS)
    • BIOINFORMATICS AS PLATFORM FOR DRUG DISCOVERY
      • Market Overview
      • Market Revenue
      • TABLE 16 GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY, THROUGH 2019 ($ MILLIONS)
      • FIGURE 9 GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY, 2012-2019 ($ MILLIONS)
    • OTHER DRUG DISCOVERY TECHNOLOGIES
      • Market Overview
      • Market Revenue
      • TABLE 17 GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY TYPE, THROUGH 2019 ($ MILLIONS)
      • FIGURE 10 GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY TYPE, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
    • TABLE 18 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES AND INSTRUMENTATIONS BY TYPE, 2013 (%)
    • FIGURE 11 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES AND INSTRUMENTATIONS BY TYPE, 2013 (%)
  • MARKET BY REGION
    • MARKET OVERVIEW
    • MARKET REVENUE
    • TABLE 19 GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 12 GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY REGION, 2012-2019 ($ MILLIONS)
    • HIGH-THROUGHPUT SCREENING
      • Market Overview
      • Market Revenue
      • TABLE 20 GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 13 GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY BY REGION, 2012-2019 ($ MILLIONS)
    • BIOANALYTICAL INSTRUMENTS FOR DRUG DISCOVERY
      • Market Overview
      • Market Revenue
      • TABLE 21 GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS FOR DRUG DISCOVERY BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 14 GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS FOR DRUG DISCOVERY BY REGION, 2012-2019 ($ MILLIONS)
      • High-performance Liquid Chromatography Equipment and Accessories
      • TABLE 22 GLOBAL REVENUE FOR HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 15 GLOBAL REVENUE FOR HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY BY REGION, 2012-2019 ($ MILLIONS)
      • Mass Spectrometry Equipment and Accessories
      • TABLE 23 GLOBAL REVENUE FOR MASS SPECTROMETRY EQUIPMENT AND ACCESSORIES BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 16 GLOBAL REVENUE FOR MASS SPECTROMETRY EQUIPMENT AND ACCESSORIES BY REGION, 2012-2019 ($ MILLIONS)
      • Nuclear Magnetic Resonance
      • TABLE 24 GLOBAL REVENUE FOR NUCLEAR MAGNETIC RESONANCE EQUIPMENT AND ACCESSORIES BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 17 GLOBAL REVENUE FOR NUCLEAR MAGNETIC RESONANCE EQUIPMENT AND ACCESSORIES BY REGION, 2012-2019 ($ MILLIONS)
      • Microscopy
      • TABLE 25 GLOBAL REVENUE FOR MICROSCOPY EQUIPMENT AND ACCESSORIES BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 18 GLOBAL REVENUE FOR MICROSCOPY EQUIPMENT AND ACCESSORIES BY REGION, 2012-2019 ($ MILLIONS)
      • X-ray Crystallography
      • TABLE 26 GLOBAL REVENUE FOR X-RAY CRYSTALLOGRAPHY EQUIPMENT AND ACCESSORIES BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 19 GLOBAL REVENUE FOR X-RAY CRYSTALLOGRAPHY EQUIPMENT AND ACCESSORIES BY REGION, 2012-2019 ($ MILLIONS)
    • CELL-BASED ASSAYS AND REAGENTS FOR DRUG DISCOVERY
      • Market Overview
      • Market Revenue
      • TABLE 27 GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS FOR DRUG DISCOVERY BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 20 GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS FOR DRUG DISCOVERY BY REGION, 2012-2019 ($ MILLIONS)
      • Cell-based Assays for Drug Discovery
      • TABLE 28 GLOBAL REVENUE FOR CELL BASED ASSAYS FOR DRUG DISCOVERY BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 21 GLOBAL REVENUE FOR CELL BASED ASSAYS FOR DRUG DISCOVERY BY REGION, 2012-2019 ($ MILLIONS)
      • Cell Biology Reagents
      • TABLE 29 GLOBAL REVENUE FOR CELL BIOLOGY REAGENTS BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 22 GLOBAL REVENUE FOR CELL BIOLOGY REAGENTS BY REGION, 2012-2019 ($ MILLIONS)
    • PROTEOMICS FOR DRUG DISCOVERY
      • Market Overview
      • Market Revenue
      • TABLE 30 GLOBAL REVENUE FOR PROTEOMICS TECHNOLOGY FOR DRUG DISCOVERY BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 23 GLOBAL REVENUE FOR PROTEOMICS TECHNOLOGY FOR DRUG DISCOVERY BY REGION, 2012-2019 ($ MILLIONS)
      • Two-dimensional Gel Electrophoresis
      • TABLE 31 GLOBAL REVENUE FOR TWO-DIMENSIONAL GEL ELECTROPHORESIS BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 24 GLOBAL REVENUE FOR TWO-DIMENSIONAL GEL ELECTROPHORESIS BY REGION, 2012-2019 ($ MILLIONS)
      • Protein Microarrays/Protein Chips
      • TABLE 32 GLOBAL REVENUE FOR PROTEIN CHIP TECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 25 GLOBAL REVENUE FOR PROTEIN CHIP TECHNOLOGY BY REGION, 2012-2019 ($ MILLIONS)
    • GENOMICS FOR DRUG DISCOVERY
      • Market Overview
      • Market Revenue
      • TABLE 33 GLOBAL REVENUE FOR GENOMICS TECHNOLOGY FOR DRUG DISCOVERY, BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 26 GLOBAL REVENUE FOR GENOMICS TECHNOLOGY FOR DRUG DISCOVERY, BY REGION, 2012-2019 ($ MILLIONS)
      • Polymerase Chain Reaction
      • TABLE 34 GLOBAL REVENUE FOR POLYMERASE CHAIN REACTION BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 27 GLOBAL REVENUE FOR POLYMERASE CHAIN REACTION BY REGION, 2012-2019 ($ MILLIONS)
      • Deoxyribonucleic Acid Microarrays
      • TABLE 35 GLOBAL REVENUE FOR DEOXYRIBONUCLEIC ACID MICROARRAYS BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 28 GLOBAL REVENUE FOR DEOXYRIBONUCLEIC ACID MICROARRAYS BY REGION, 2012-2019 ($ MILLIONS)
      • Ribonucleic Acid Interference
      • TABLE 36 GLOBAL REVENUE FOR RIBONUCLEIC ACID INTERFERENCE TECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 29 GLOBAL REVENUE FOR RIBONUCLEIC ACID INTERFERENCE TECHNOLOGY BY REGION, 2012-2019 ($ MILLIONS)
      • Next-Generation Sequencing
      • TABLE 37 GLOBAL REVENUE FOR NEXT-GENERATION SEQUENCING TECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 30 GLOBAL REVENUE FOR NEXT-GENERATION SEQUENCING TECHNOLOGY BY REGION, 2012-2019 ($ MILLIONS)
      • Epigenetics
      • TABLE 38 GLOBAL REVENUE FOR EPIGENETICS TECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 31 GLOBAL REVENUE FOR EPIGENETICS TECHNOLOGY BY REGION, 2012- 2019 ($ MILLIONS)
    • BIOINFORMATICS FOR DRUG DISCOVERY
      • Market Overview
      • Market Revenue
      • TABLE 39 GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY FOR DRUG DISCOVERY BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 32 GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY FOR DRUG DISCOVERY BY REGION, 2012-2019 ($ MILLIONS)
    • OTHER DRUG DISCOVERY TECHNOLOGIES
      • Market Overview
      • Market Revenue
      • TABLE 40 GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 33 GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY REGION, 2012-2019 ($ MILLIONS)
      • Metabolomics
      • TABLE 41 GLOBAL REVENUE FOR METABOLOMICS TECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 34 GLOBAL REVENUE FOR METABOLOMICS TECHNOLOGY BY REGION, 2012-2019 ($ MILLIONS)
      • Combinatorial Chemistry
      • TABLE 42 GLOBAL REVENUE FOR COMBINATORIAL CHEMISTRY BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 35 GLOBAL REVENUE FOR COMBINATORIAL CHEMISTRY BY REGION, 2012-2019 ($ MILLIONS)
      • Systems Biology
      • TABLE 43 GLOBAL REVENUE FOR SYSTEMS BIOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 36 GLOBAL REVENUE FOR SYSTEMS BIOLOGY BY REGION, 2012-2019 ($ MILLIONS)
      • Nanotechnology
      • TABLE 44 GLOBAL REVENUE FOR NANOTECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 37 GLOBAL REVENUE FOR NANOTECHNOLOGY BY REGION, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 45 TABLE 45 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES BY REGION, 2013 (%)
      • FIGURE 38 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES BY REGION, 2013 (%)

CHAPTER 7 INDUSTRY STRUCTURE

  • HIGH-THROUGHPUT SCREENING
    • MARKET LEADERS
    • TABLE 46 LEADING MANUFACTURERS/SUPPLIERS OF HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2013
    • MARKET SHARE
    • TABLE 47 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2013 (%)
    • FIGURE 39 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2013 (%)
  • BIOANALYTICAL INSTRUMENTS
    • MARKET LEADERS
    • TABLE 48 LEADING MANUFACTURERS/SUPPLIERS OF BIOANALYTICAL INSTRUMENTS, 2013
    • MARKET SHARE
    • TABLE 49 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR BIOANALYTICAL INSTRUMENTS, 2013 (%)
    • FIGURE 40 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR BIOANALYTICAL INSTRUMENTS, 2013 (%)
  • CELL-BASED ASSAYS AND REAGENTS
    • MARKET LEADERS
    • TABLE 50 LEADING MANUFACTURERS/SUPPLIERS OF CELL-BASED ASSAYS AND REAGENTS, 2013
    • MARKET SHARE
    • TABLE 51 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR CELL-BASED ASSAYS AND REAGENTS, 2013 (%)
    • FIGURE 41 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR CELL-BASED ASSAYS AND REAGENTS, 2013 (%)
  • PROTEOMICS
    • MARKET LEADERS
    • TABLE 52 LEADING MANUFACTURERS/SUPPLIERS OF PROTEOMICS TECHNOLOGY, 2013
    • MARKET SHARE
    • TABLE 53 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR PROTEOMICS TECHNOLOGY, 2013 (%)
    • FIGURE 42 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR PROTEOMICS TECHNOLOGY, 2013 (%)
  • GENOMICS
    • MARKET LEADERS
    • TABLE 54 LEADING MANUFACTURERS/SUPPLIERS OF GENOMICS TECHNOLOGY, 2013
    • MARKET SHARE
    • TABLE 55 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR GENOMICS TECHNOLOGY, 2013 (%)
    • FIGURE 43 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR GENOMICS TECHNOLOGY, 2013 (%)
  • BIOINFORMATICS
    • MARKET LEADERS
    • TABLE 56 LEADING MANUFACTURERS/SUPPLIERS OF BIOINFORMATICS TECHNOLOGY, 2013
    • MARKET SHARE
    • TABLE 57 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR BIOINFORMATICS TECHNOLOGY, 2013 (%)
    • FIGURE 44 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR BIOINFORMATICS TECHNOLOGY, 2013 (%)
  • OTHER DRUG DISCOVERY TECHNOLOGIES
    • MARKET LEADERS
    • TABLE 58 LEADING MANUFACTURERS/SUPPLIERS OF OTHER DRUG DISCOVERY TECHNOLOGIES, 2013
    • MARKET SHARE
    • TABLE 59 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2013 (%)
    • FIGURE 45 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2013 (%)

CHAPTER 8 MARKET BY APPLICATION

  • INDUSTRIAL PHARMACEUTICAL/ BIOPHARMACEUTICAL MANUFACTURING
  • PHARMACEUTICAL/ BIOPHARMACEUTICAL RESEARCH AND DEVELOPMENT
  • GLOBAL DRUG DISCOVERY TECHNOLOGY MARKET BY APPLICATION
  • TABLE 60 GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, THROUGH 2019 ($ MILLIONS)
  • FIGURE 46 GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
    • TABLE 61 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, 2013 (%)
    • FIGURE 47 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, 2013 (%)
  • HIGH-THROUGHPUT SCREENING
    • MARKET OVERVIEW
    • MARKET REVENUE
    • TABLE 62 GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 48 GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY BY APPLICATION, 2012-2019 ($ MILLIONS)
  • BIOANALYTICAL INSTRUMENTS
    • MARKET OVERVIEW
    • MARKET REVENUE
    • TABLE 63 GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 49 GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS BY APPLICATION, 2012-2019 ($ MILLIONS)
  • CELL-BASED ASSAYS AND REAGENTS
    • MARKET OVERVIEW
    • MARKET REVENUE
    • TABLE 64 GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 50 GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS BY APPLICATION, 2012-2019 ($ MILLIONS)
  • PROTEOMICS TECHNOLOGY
    • MARKET OVERVIEW
    • MARKET REVENUE
    • TABLE 65 GLOBAL REVENUE FOR PROTEOMICS TECHNOLOGY BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 51 GLOBAL REVENUE FOR PROTEOMICS TECHNOLOGY BY APPLICATION, 2012-2019 ($ MILLIONS)
  • GENOMICS TECHNOLOGY
    • MARKET OVERVIEW
    • MARKET REVENUE
    • TABLE 66 GLOBAL REVENUE FOR GENOMICS TECHNOLOGY BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 52 GLOBAL REVENUE FOR GENOMICS TECHNOLOGY BY APPLICATION, 2012-2019 ($ MILLIONS)
  • BIOINFORMATICS TECHNOLOGY
    • MARKET OVERVIEW
    • MARKET REVENUE
    • TABLE 67 GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 53 GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY BY APPLICATION, 2012-2019 ($ MILLIONS)
  • OTHER DRUG DISCOVERY TECHNOLOGIES
    • MARKET OVERVIEW
    • MARKET REVENUE
    • TABLE 68 GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 54 GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, 2012-2019 ($ MILLIONS)

CHAPTER 9 PATENT ANALYSIS

  • PATENTS BY YEAR
  • TABLE 69 TOTAL NUMBER OF U.S. PATENTS BY YEAR, 2012 TO JULY 2014 (NUMBER)
  • FIGURE 55 TOTAL NUMBER OF U.S. PATENTS BY YEAR, 2012 TO JULY 2014 (NUMBER)
  • PATENTS BY DRUG DISCOVERY TECHNOLOGIES AND PRODUCT TYPE
  • TABLE 70 NUMBER OF U.S. PATENTS BY DRUG DISCOVERY TECHNOLOGIES AND PRODUCTS CATEGORY, 2012 TO JULY 2014 (NUMBER)
  • PATENTS BY COUNTRY
    • HIGH-THROUGHPUT SCREENING TECHNOLOGY
    • TABLE 71 NUMBER OF U.S. PATENTS BY COUNTRY FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014 (NUMBER)
    • TABLE 72 PATENT SHARES BY COUNTRY FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014 (%)
    • FIGURE 56 PATENT SHARES BY COUNTRY FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014 (%)
    • BIOANALYTICAL INSTRUMENTS
    • TABLE 73 NUMBER OF U.S. PATENTS BY COUNTRY FOR BIOANALYTICAL INSTRUMENTS, 2012 TO JULY 2014 (NUMBER)
    • TABLE 74 PATENT SHARES BY COUNTRY FOR BIOANALYTICAL INSTRUMENTS, 2012 TO JULY 2014 (%)
    • CELL-BASED ASSAYS AND REAGENTS
    • TABLE 75 NUMBER OF U.S. PATENTS BY COUNTRY FOR CELL-BASED ASSAYS AND REAGENTS, 2012 TO JULY 2014 (NUMBER)
    • TABLE 76 PATENT SHARES BY COUNTRY FOR CELL-BASED ASSAYS AND REAGENTS, 2012 TO JULY 2014 (%)
    • PROTEOMICS
    • TABLE 77 NUMBER OF U.S. PATENTS BY COUNTRY FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
    • TABLE 78 PATENT SHARES BY COUNTRY FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (%)
    • GENOMICS
    • TABLE 79 NUMBER OF U.S. PATENTS BY COUNTRY FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
    • TABLE 80 PATENT SHARES BY COUNTRY FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (%)
    • FIGURE 57 PATENT SHARES BY COUNTRY FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (%)
    • BIOINFORMATICS PLATFORM
    • TABLE 81 NUMBER OF U.S. PATENTS BY COUNTRY FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014 (NUMBER)
    • TABLE 82 PATENT SHARES BY COUNTRY FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014 (%)
    • FIGURE 58 PATENT SHARES BY COUNTRY FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014 (%)
    • OTHER DRUG DISCOVERY TECHNOLOGIES
    • TABLE 83 NUMBER OF U.S. PATENTS BY COUNTRY FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
    • TABLE 84 PATENT SHARES BY COUNTRY FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (%)
    • FIGURE 59 PATENT SHARES BY COUNTRY FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012-2014 (JULY) (%)
  • PATENTS BY COMPANY
    • HIGH-THROUGHPUT SCREENING TECHNOLOGY
    • TABLE 85 NUMBER OF U.S. PATENTS BY COMPANY FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014 (NUMBER)
    • BIOANALYTICAL INSTRUMENTS
    • TABLE 86 NUMBER OF U.S. PATENTS BY COMPANY FOR BIOANALYTICAL INSTRUMENTS, 2012 TO JULY 2014 (NUMBER)
    • CELL-BASED ASSAYS AND REAGENTS
    • TABLE 87 NUMBER OF U.S. PATENTS BY COMPANY FOR CELL-BASED ASSAYS AND REAGENTS, 2012 TO JULY 2014 (NUMBER)
    • PROTEOMICS
    • TABLE 88 NUMBER OF U.S. PATENTS BY COMPANY FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
    • GENOMICS
    • TABLE 89 NUMBER OF U.S. PATENTS BY COMPANY FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
    • BIOINFORMATICS PLATFORM
    • TABLE 90 NUMBER OF U.S. PATENTS BY COMPANY FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014 (NUMBER)
    • OTHER DRUG DISCOVERY TECHNOLOGIES
    • TABLE 91 NUMBER OF U.S. PATENTS BY COMPANY FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
  • PATENTS BY ASSIGNEE
    • HIGH-THROUGHPUT SCREENING TECHNOLOGY
    • TABLE 92 U.S. PATENTS BY ASSIGNEE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014 (NUMBER)
    • BIOANALYTICAL INSTRUMENTS
    • TABLE 93 U.S. PATENTS BY ASSIGNEE FOR BIOANALYTICAL INSTRUMENTS, 2012 TO JULY 2014 (NUMBER)
    • CELL-BASED ASSAYS AND REAGENTS
    • TABLE 94 U.S. PATENTS BY ASSIGNEE FOR CELL-BASED ASSAYS AND REAGENTS, 2012 TO JULY 2014 (NUMBER)
    • PROTEOMICS
    • TABLE 95 U.S. PATENTS BY ASSIGNEE FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
    • GENOMICS
    • TABLE 96 U.S. PATENTS BY ASSIGNEE FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
    • BIOINFORMATICS PLATFORM
    • TABLE 97 U.S. PATENTS BY ASSIGNEE FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014 (NUMBER)
    • OTHER DRUG DISCOVERY TECHNOLOGIES
    • TABLE 98 U.S. PATENTS BY ASSIGNEE FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)

CHAPTER 10 CURRENT SITUATION

  • NEW DRUG DISCOVERY TECHNOLOGIES AND PLATFORMS
    • NANOPARTICLE TRACKING ANALYSIS
    • AUTOFLUORESCENCE REDUCTION TECHNOLOGY
    • BIOCEL SYSTEM
    • BIONUMERICS
    • GENEVATM GENOMIC MARKERS DISCOVERY PLATFORM
  • FACTORS AFFECTING THE MARKET FOR DRUG DISCOVERY TECHNOLOGIES
  • CURRENT DRIVERS FOR THE MARKET OF DRUG DISCOVERY TECHNOLOGIES
  • COLLABORATIONS/ACQUISITIONS

CHAPTER 11 COMPANY PROFILES

  • AB SCIEX
  • ACCELRYS (NOW BIOVIA)
  • AFFYMETRIX INC.
  • AGILENT TECHNOLOGIES INC
  • AMETEK PROCESS INSTRUMENTS
  • APPLIED MATHS NV
  • BAYER TECHNOLOGY SERVICES GMBH
  • BD BIOSCIENCES
  • BECKMAN COULTER INC.
  • BIOCRATES LIFE SCIENCES AG
  • BIOMAX INFORMATICS AG
  • BIO-RAD LABORATORIES INC.
  • BIOTECH SUPPORT GROUP
  • BIOTEK INSTRUMENTS INC.
  • BRUKER
  • CEPHEID
  • CHARLES RIVER LABORATORIES INTERNATIONAL INC.
  • CHENOMX
  • CISBIO BIOASSAYS
  • CODEX BIOSOLUTIONS INC.
  • COMPUGEN LTD.
  • EMD MILLIPORE
  • GE HEALTHCARE LIFESCIENCES
  • GENEVA BIOINFORMATICS SA
  • GENOMATIX SOFTWARE GMBH
  • GENOSPLICE TECHNOLOGY
  • HAMILTON ROBOTICS INC.
  • HIGHCHEM LTD. SLOVAKIA
  • HITACHI HIGH-TECHNOLOGIES CORP.
  • HUMAN METABOLOME TECHNOLOGIES INC.
  • ILLUMINA INC.
  • INTEGRATED DNA TECHNOLOGIES INC.
  • IROA TECHNOLOGIES (FORMERLY NEXTGEN METABOLOMICS)
  • JEOL LTD
  • LEICA MICROSYSTEMS
  • LONZA GROUP AG
  • METABOLON INC.
  • MOLECULAR DEVICES LLC
  • MULTISPAN INC.
  • OPGEN INC.
  • PERKINELMER INC.
  • PROMEGA CORP.
  • QIAGEN NV
  • ROCHE HOLDING LTD
  • SHIMADZU
  • SIDMAP LLC
  • SIGMA-ALDRICH CORP.
  • SOMALOGIC INC.
  • THERMO FISHER SCIENTIFIC INC.
  • THOMSON REUTERS
  • WATERS CORP.
  • ZEISS

CHAPTER 12 APPENDIX-ABBREVIATIONS

LIST OF TABLES

  • SUMMARY TABLE GLOBAL REVENUE OF DRUG DISCOVERY TECHNOLOGIES, BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 1 CELL BIOLOGY REAGENTS AND THEIR FUNCTIONS
  • TABLE 2 PROTEIN MICROARRAY AND THEIR FUNCTIONS
  • TABLE 3 DIFFERENCE BETWEEN SOLID-PHASE AND SOLUTION-PHASE SYNTHESIS
  • TABLE 4 NEW DEVELOPMENTS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2014
  • TABLE 5 AWARDS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2014
  • TABLE 6 NEW DEVELOPMENTS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2013
  • TABLE 7 AWARDS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2013
  • TABLE 8 NEW DEVELOPMENTS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2012
  • TABLE 9 AWARDS FOR DRUG DEVELOPMENT TECHNOLOGIES, 2012
  • TABLE 10 GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY TYPE, THROUGH 2019 ($ MILLIONS)
  • TABLE 11 GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, THROUGH 2019 ($ MILLIONS)
  • TABLE 12 GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS AND TECHNOLOGY, BY TYPE, THROUGH 2019 ($ MILLIONS)
  • TABLE 13 GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS BY TYPE, THROUGH 2019 ($ MILLIONS)
  • TABLE 14 GLOBAL REVENUE FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGY BY TYPE, THROUGH 2019 ($ MILLIONS)
  • TABLE 15 GLOBAL REVENUE FOR GENOMIC DRUG DISCOVERY TECHNOLOGY BY TYPE, THROUGH 2019 ($ MILLIONS)
  • TABLE 16 GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY, THROUGH 2019 ($ MILLIONS)
  • TABLE 17 GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY TYPE, THROUGH 2019 ($ MILLIONS)
  • TABLE 18 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES AND INSTRUMENTATIONS BY TYPE, 2013 (%)
  • TABLE 19 GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 20 GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 21 GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS FOR DRUG DISCOVERY BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 22 GLOBAL REVENUE FOR HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 23 GLOBAL REVENUE FOR MASS SPECTROMETRY EQUIPMENT AND ACCESSORIES BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 24 GLOBAL REVENUE FOR NUCLEAR MAGNETIC RESONANCE EQUIPMENT AND ACCESSORIES BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 25 GLOBAL REVENUE FOR MICROSCOPY EQUIPMENT AND ACCESSORIES BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 26 GLOBAL REVENUE FOR X-RAY CRYSTALLOGRAPHY EQUIPMENT AND ACCESSORIES BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 27 GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS FOR DRUG DISCOVERY BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 28 GLOBAL REVENUE FOR CELL BASED ASSAYS FOR DRUG DISCOVERY BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 29 GLOBAL REVENUE FOR CELL BIOLOGY REAGENTS BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 30 GLOBAL REVENUE FOR PROTEOMICS TECHNOLOGY FOR DRUG DISCOVERY BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 31 GLOBAL REVENUE FOR TWO-DIMENSIONAL GEL ELECTROPHORESIS BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 32 GLOBAL REVENUE FOR PROTEIN CHIP TECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 33 GLOBAL REVENUE FOR GENOMICS TECHNOLOGY FOR DRUG DISCOVERY, BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 34 GLOBAL REVENUE FOR POLYMERASE CHAIN REACTION BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 35 GLOBAL REVENUE FOR DEOXYRIBONUCLEIC ACID MICROARRAYS BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 36 GLOBAL REVENUE FOR RIBONUCLEIC ACID INTERFERENCE TECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 37 GLOBAL REVENUE FOR NEXT-GENERATION SEQUENCING TECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 38 GLOBAL REVENUE FOR EPIGENETICS TECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 39 GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY FOR DRUG DISCOVERY BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 40 GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 41 GLOBAL REVENUE FOR METABOLOMICS TECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 42 GLOBAL REVENUE FOR COMBINATORIAL CHEMISTRY BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 43 GLOBAL REVENUE FOR SYSTEMS BIOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 44 GLOBAL REVENUE FOR NANOTECHNOLOGY BY REGION, THROUGH 2019 ($ MILLIONS)
  • TABLE 45 TABLE 45 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES BY REGION, 2013 (%)
  • TABLE 46 LEADING MANUFACTURERS/SUPPLIERS OF HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2013
  • TABLE 47 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2013 (%)
  • TABLE 48 LEADING MANUFACTURERS/SUPPLIERS OF BIOANALYTICAL INSTRUMENTS, 2013
  • TABLE 49 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR BIOANALYTICAL INSTRUMENTS, 2013 (%)
  • TABLE 50 LEADING MANUFACTURERS/SUPPLIERS OF CELL-BASED ASSAYS AND REAGENTS, 2013
  • TABLE 51 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR CELL-BASED ASSAYS AND REAGENTS, 2013 (%)
  • TABLE 52 LEADING MANUFACTURERS/SUPPLIERS OF PROTEOMICS TECHNOLOGY, 2013
  • TABLE 53 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR PROTEOMICS TECHNOLOGY, 2013 (%)
  • TABLE 54 LEADING MANUFACTURERS/SUPPLIERS OF GENOMICS TECHNOLOGY, 2013
  • TABLE 55 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR GENOMICS TECHNOLOGY, 2013 (%)
  • TABLE 56 LEADING MANUFACTURERS/SUPPLIERS OF BIOINFORMATICS TECHNOLOGY, 2013
  • TABLE 57 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR BIOINFORMATICS TECHNOLOGY, 2013 (%)
  • TABLE 58 LEADING MANUFACTURERS/SUPPLIERS OF OTHER DRUG DISCOVERY TECHNOLOGIES, 2013
  • TABLE 59 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2013 (%)
  • TABLE 60 GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, THROUGH 2019 ($ MILLIONS)
  • TABLE 61 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, 2013 (%)
  • TABLE 62 GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY BY APPLICATION, THROUGH 2019 ($ MILLIONS)
  • TABLE 63 GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS BY APPLICATION, THROUGH 2019 ($ MILLIONS)
  • TABLE 64 GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS BY APPLICATION, THROUGH 2019 ($ MILLIONS)
  • TABLE 65 GLOBAL REVENUE FOR PROTEOMICS TECHNOLOGY BY APPLICATION, THROUGH 2019 ($ MILLIONS)
  • TABLE 66 GLOBAL REVENUE FOR GENOMICS TECHNOLOGY BY APPLICATION, THROUGH 2019 ($ MILLIONS)
  • TABLE 67 GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY BY APPLICATION, THROUGH 2019 ($ MILLIONS)
  • TABLE 68 GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, THROUGH 2019 ($ MILLIONS)
  • TABLE 69 TOTAL NUMBER OF U.S. PATENTS BY YEAR, 2012 TO JULY 2014 (NUMBER)
  • TABLE 70 NUMBER OF U.S. PATENTS BY DRUG DISCOVERY TECHNOLOGIES AND PRODUCTS CATEGORY, 2012 TO JULY 2014 (NUMBER)
  • TABLE 71 NUMBER OF U.S. PATENTS BY COUNTRY FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014 (NUMBER)
  • TABLE 72 PATENT SHARES BY COUNTRY FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014 (%)
  • TABLE 73 NUMBER OF U.S. PATENTS BY COUNTRY FOR BIOANALYTICAL INSTRUMENTS, 2012 TO JULY 2014 (NUMBER)
  • TABLE 74 PATENT SHARES BY COUNTRY FOR BIOANALYTICAL INSTRUMENTS, 2012 TO JULY 2014 (%)
  • TABLE 75 NUMBER OF U.S. PATENTS BY COUNTRY FOR CELL-BASED ASSAYS AND REAGENTS, 2012 TO JULY 2014 (NUMBER)
  • TABLE 76 PATENT SHARES BY COUNTRY FOR CELL-BASED ASSAYS AND REAGENTS, 2012 TO JULY 2014 (%)
  • TABLE 77 NUMBER OF U.S. PATENTS BY COUNTRY FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
  • TABLE 78 PATENT SHARES BY COUNTRY FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (%)
  • TABLE 79 NUMBER OF U.S. PATENTS BY COUNTRY FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
  • TABLE 80 PATENT SHARES BY COUNTRY FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (%)
  • TABLE 81 NUMBER OF U.S. PATENTS BY COUNTRY FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014 (NUMBER)
  • TABLE 82 PATENT SHARES BY COUNTRY FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014 (%)
  • TABLE 83 NUMBER OF U.S. PATENTS BY COUNTRY FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
  • TABLE 84 PATENT SHARES BY COUNTRY FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (%)
  • TABLE 85 NUMBER OF U.S. PATENTS BY COMPANY FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014 (NUMBER)
  • TABLE 86 NUMBER OF U.S. PATENTS BY COMPANY FOR BIOANALYTICAL INSTRUMENTS, 2012 TO JULY 2014 (NUMBER)
  • TABLE 87 NUMBER OF U.S. PATENTS BY COMPANY FOR CELL-BASED ASSAYS AND REAGENTS, 2012 TO JULY 2014 (NUMBER)
  • TABLE 88 NUMBER OF U.S. PATENTS BY COMPANY FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
  • TABLE 89 NUMBER OF U.S. PATENTS BY COMPANY FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
  • TABLE 90 NUMBER OF U.S. PATENTS BY COMPANY FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014 (NUMBER)
  • TABLE 91 NUMBER OF U.S. PATENTS BY COMPANY FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
  • TABLE 92 U.S. PATENTS BY ASSIGNEE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014 (NUMBER)
  • TABLE 93 U.S. PATENTS BY ASSIGNEE FOR BIOANALYTICAL INSTRUMENTS, 2012 TO JULY 2014 (NUMBER)
  • TABLE 94 U.S. PATENTS BY ASSIGNEE FOR CELL-BASED ASSAYS AND REAGENTS, 2012 TO JULY 2014 (NUMBER)
  • TABLE 95 U.S. PATENTS BY ASSIGNEE FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
  • TABLE 96 U.S. PATENTS BY ASSIGNEE FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)
  • TABLE 97 U.S. PATENTS BY ASSIGNEE FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014 (NUMBER)
  • TABLE 98 U.S. PATENTS BY ASSIGNEE FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (NUMBER)

LIST OF FIGURES

  • SUMMARY FIGURE GLOBAL REVENUE OF DRUG DISCOVERY TECHNOLOGIES, BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 1 DRUG DISCOVERY PROCESS
  • FIGURE 2 STEPS TO DRUG DISCOVERY UNTIL REGULATORY APPROVAL
  • FIGURE 3 GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY TYPE, 2012-2019 ($ MILLIONS)
  • FIGURE 4 GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012-2019 ($ MILLIONS)
  • FIGURE 5 GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS AND TECHNOLOGY, BY TYPE, 2012-2019 ($ MILLIONS)
  • FIGURE 6 GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS BY TYPE, 2012-2019 ($ MILLIONS)
  • FIGURE 7 GLOBAL REVENUE FOR PROTEOMICS DRUG DISCOVERY TECHNOLOGY BY TYPE, 2012-2019 ($ MILLIONS)
  • FIGURE 8 GLOBAL REVENUE FOR GENOMIC DRUG DISCOVERY TECHNOLOGY BY TYPE, 2012-2019 ($ MILLIONS)
  • FIGURE 9 GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY, 2012-2019 ($ MILLIONS)
  • FIGURE 10 GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY TYPE, 2012-2019 ($ MILLIONS)
  • FIGURE 11 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES AND INSTRUMENTATIONS BY TYPE, 2013 (%)
  • FIGURE 12 GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 13 GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 14 GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS FOR DRUG DISCOVERY BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 15 GLOBAL REVENUE FOR HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 16 GLOBAL REVENUE FOR MASS SPECTROMETRY EQUIPMENT AND ACCESSORIES BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 17 GLOBAL REVENUE FOR NUCLEAR MAGNETIC RESONANCE EQUIPMENT AND ACCESSORIES BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 18 GLOBAL REVENUE FOR MICROSCOPY EQUIPMENT AND ACCESSORIES BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 19 GLOBAL REVENUE FOR X-RAY CRYSTALLOGRAPHY EQUIPMENT AND ACCESSORIES BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 20 GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS FOR DRUG DISCOVERY BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 21 GLOBAL REVENUE FOR CELL BASED ASSAYS FOR DRUG DISCOVERY BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 22 GLOBAL REVENUE FOR CELL BIOLOGY REAGENTS BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 23 GLOBAL REVENUE FOR PROTEOMICS TECHNOLOGY FOR DRUG DISCOVERY BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 24 GLOBAL REVENUE FOR TWO-DIMENSIONAL GEL ELECTROPHORESIS BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 25 GLOBAL REVENUE FOR PROTEIN CHIP TECHNOLOGY BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 26 GLOBAL REVENUE FOR GENOMICS TECHNOLOGY FOR DRUG DISCOVERY, BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 27 GLOBAL REVENUE FOR POLYMERASE CHAIN REACTION BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 28 GLOBAL REVENUE FOR DEOXYRIBONUCLEIC ACID MICROARRAYS BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 29 GLOBAL REVENUE FOR RIBONUCLEIC ACID INTERFERENCE TECHNOLOGY BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 30 GLOBAL REVENUE FOR NEXT-GENERATION SEQUENCING TECHNOLOGY BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 31 GLOBAL REVENUE FOR EPIGENETICS TECHNOLOGY BY REGION, 2012- 2019 ($ MILLIONS)
  • FIGURE 32 GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY FOR DRUG DISCOVERY BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 33 GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 34 GLOBAL REVENUE FOR METABOLOMICS TECHNOLOGY BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 35 GLOBAL REVENUE FOR COMBINATORIAL CHEMISTRY BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 36 GLOBAL REVENUE FOR SYSTEMS BIOLOGY BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 37 GLOBAL REVENUE FOR NANOTECHNOLOGY BY REGION, 2012-2019 ($ MILLIONS)
  • FIGURE 38 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES BY REGION, 2013 (%)
  • FIGURE 39 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2013 (%)
  • FIGURE 40 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR BIOANALYTICAL INSTRUMENTS, 2013 (%)
  • FIGURE 41 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR CELL-BASED ASSAYS AND REAGENTS, 2013 (%)
  • FIGURE 42 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR PROTEOMICS TECHNOLOGY, 2013 (%)
  • FIGURE 43 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR GENOMICS TECHNOLOGY, 2013 (%)
  • FIGURE 44 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR BIOINFORMATICS TECHNOLOGY, 2013 (%)
  • FIGURE 45 MARKET SHARES OF MANUFACTURERS/SUPPLIERS FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2013 (%)
  • FIGURE 46 GLOBAL REVENUE FOR DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, 2012-2019 ($ MILLIONS)
  • FIGURE 47 MARKET SHARE OF DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, 2013 (%)
  • FIGURE 48 GLOBAL REVENUE FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY BY APPLICATION, 2012-2019 ($ MILLIONS)
  • FIGURE 49 GLOBAL REVENUE FOR BIOANALYTICAL INSTRUMENTS BY APPLICATION, 2012-2019 ($ MILLIONS)
  • FIGURE 50 GLOBAL REVENUE FOR CELL-BASED ASSAYS AND REAGENTS BY APPLICATION, 2012-2019 ($ MILLIONS)
  • FIGURE 51 GLOBAL REVENUE FOR PROTEOMICS TECHNOLOGY BY APPLICATION, 2012-2019 ($ MILLIONS)
  • FIGURE 52 GLOBAL REVENUE FOR GENOMICS TECHNOLOGY BY APPLICATION, 2012-2019 ($ MILLIONS)
  • FIGURE 53 GLOBAL REVENUE FOR BIOINFORMATICS TECHNOLOGY BY APPLICATION, 2012-2019 ($ MILLIONS)
  • FIGURE 54 GLOBAL REVENUE FOR OTHER DRUG DISCOVERY TECHNOLOGIES BY APPLICATION, 2012-2019 ($ MILLIONS)
  • FIGURE 55 TOTAL NUMBER OF U.S. PATENTS BY YEAR, 2012 TO JULY 2014 (NUMBER)
  • FIGURE 56 PATENT SHARES BY COUNTRY FOR HIGH-THROUGHPUT SCREENING TECHNOLOGY, 2012 TO JULY 2014 (%)
  • FIGURE 57 PATENT SHARES BY COUNTRY FOR GENOMICS DRUG DISCOVERY TECHNOLOGIES, 2012 TO JULY 2014 (%)
  • FIGURE 58 PATENT SHARES BY COUNTRY FOR BIOINFORMATICS PLATFORM, 2012 TO JULY 2014 (%)
  • FIGURE 59 PATENT SHARES BY COUNTRY FOR OTHER DRUG DISCOVERY TECHNOLOGIES, 2012-2014 (JULY) (%)
Back to Top